Andorsky, David J <br/><br/>
An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.  [electronic resource] 

 -  British journal of haematology  01 2019 
 - 215-222 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.15552  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Female<br/>Humans<br/>Indazoles--administration & dosage<br/>Lymphoma, B-Cell, Marginal Zone--drug therapy<br/>Lymphoma, Follicular--drug therapy<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Pyrazines--administration & dosage<br/>Syk Kinase--antagonists & inhibitors<br/>Waldenstrom Macroglobulinemia--drug therapy